AF termination is reversible, and the implantation of permanent cardiac pacemaker may not be necessary. [6] Although some PAF patients will need permanent pacemaker implantation after ablation, Miyanaga et al. found [7] that the mean heart rate did not significantly change in preexisting SND patients after catheter-based pulmonary vein isolation (PVI) for PAF. This can be attributed to the fact that structural remodeling throughout the atrium and in the sinus node region is less reversible than electrical remodeling. It is difficult to know which patients have prolonged pauses and PAF and which should be treated with a pacemaker after ablation. To address this issue, we investigated the electrophysiological characteristics, clinical characteristics, and sinus node function in patients with prolonged pauses and PAF.
mEthods

Study population
Between January 2011 and December 2014, 486 consecutive patients were referred to our center for PAF treated by radiofrequency catheter ablation (RFCA). Among them, 28 (5.76%) patients presented with prolonged pauses (>3 s). All of these patients had syncope or presyncope associated with either sinus bradycardia or prolonged sinus pauses which were an indication for permanent pacemaker implantation. These patients underwent intracardiac electrophysiological study (EPS) before the radiofrequency ablation procedure. Patients were classified in either a normal sinus node function (NSF) group or an SND group based on the EPS. SND was defined as corrected sinus node recovery time (CSNRT) longer than 550 ms in >2 cycle lengths. [8] Eleven patients (39.3%) were placed in the NSF group and 17 (60.7%) patients in the SND group. All patients had prolonged sinus pauses associated with episodes of syncope or presyncope as detected by 24 h Dynamic Electrocardiography (ECG, Holter) without antiarrhythmic or rate-controlling drugs (including calcium channel blockers, ß-blockers, and amiodarone). These patients preferred to undergo RFCA for PAF rather than to receive pacemaker implantation. Prolonged pauses were defined as a history of presyncope or syncope secondary to pauses lasting more than 3 s. Pauses were defined as durations of longer than 2 s with the absence of any QRS complexes. [9] Long pauses were defined as durations of longer than 3 s with the absence of any QRS complexes. Patients were excluded from the study if they had recent (≤3 months) myocardial infarction, ongoing myocardial ischemia, heart failure, or valvular heart disease. Written informed consent for catheter ablation and participation in the study was obtained from all patients. This study was approved by our Clinical Research and Ethics Committee.
Holter electrocardiography and electrophysiological study
Three-channel Holter ECG recordings were obtained for 24 h the day before and after the RFCA and were analyzed using an automatic analysis system (MARS -3000, General Electric Company, USA). EPS was performed during a fasting and sedated state. Surface ECG and bipolar endocardial electrograms were stored continuously for further analysis. Bipolar recordings were filtered from 30 to 500 Hz. Standard stimulation and recording techniques were used. The sinus node function was evaluated at the beginning of the procedure in all cases. The sinus node recovery time (SNRT) was measured by right atrial pacing for 30 s at decreasing pacing cycle lengths from 600 to 300 ms, which was then determined as the longest time from the stimulus artifact to the earliest sinus node activity. The CSNRT was calculated as the difference between the SNRT and baseline cycle length. SND was defined as CSNRT longer than 550 ms in >2 cycle lengths. [8] The mean, maximum, and minimum heart rates were determined by 24 h ambulatory monitoring before and after the ablation.
Catheter ablation
Before catheter ablation, all PAF patients underwent transoesophageal echocardiography to exclude intracardiac thrombi. Warfarin was discontinued, and low-molecular heparin was used 3 days' preablation in PAF patients. Catheter ablation procedures were classified according to the arrhythmias induced using standard electrophysiological techniques and definitions. Ablation was guided by use of a three-dimensional mapping system (CARTO system, Biosense Webster Inc. USA). The complete PVI was performed with a target temperature of 50° C and a power limit of 30 W for 30-60 s. The endpoint of the PVI was the establishment of the bidirectional conduction block between the left atria (LA) and pulmonary vein (PV), confirmed by the elimination of the PV potentials and the absence of PV to LA conductions. In patients with a history of common right atrial flutter, the bidirectional block of the cavotricuspid isthmus was created in the same session.
Follow-up
All patients were monitored in hospital for at least 3 days after ablation with a daily 12-lead ECG recording and physical examination. Patients were given a periodic follow-up and were clinically reevaluated by 24 h ambulatory monitoring at 1, 3, 6, 12, 18, and 24 months after ablation. All antiarrhythmic drugs were ceased in the absence of concurrent indications after ablation. Any episode of symptomatic or asymptomatic atrial tachyarrhythmias lasting over 30 s with ECG/Holter documentation was considered a recurrence. Re-ablation was performed at least 1 month after the initial procedure.
Statistical analysis
All variables were presented as mean ± standard deviation. Comparison between groups was performed using Student's t-test (unpaired). Proportions were compared using Chi-square test analysis. Multivariate logistic regression was used to determine the correlation of baseline characteristics to SND. Differences with P < 0.05 were considered statistically significant.
rEsults
Patient characteristics
The clinical characteristics of the NSF group (11 patients -8 men, 3 women; age 30-72 years, mean 48.2 ± 9.3 years) and the SND group (17 patients -12 men, 5 women; age 37-75 years, mean 62.2 ± 7.5 years) are presented in Table 1 . The mean maximum symptomatic prolonged pause on termination of tachycardias was 5.2 ± 2.4 s (3.4-12.6 s). A sample ECG administered is shown in Figure 1 . No significant differences were seen in gender, left atrial dimension, left ventricular ejection fraction (LVEF), blood pressure, or the longest pause between the two groups. The mean age of patients was older and the frequency of pauses seen was greater. The mean, minimum, and maximum heart rates were lower and smaller in SND group patients. The prolonged sinus pause only on the termination of PAF occurred in 13 patients, while the onset of prolonged pauses was not observed under sinus rhythm or during tachyarrhythmia in 15 patients.
Clinical outcome of ablation and electrophysiological characteristics
RFCA was successful in 28 patients with no serious complications noted after the procedures. Electrophysiological data in the two groups are illustrated in Table 2 . Before the RFCA, CSNRT was 409 ± 152 ms in the NSF group, and 558 ± 178 ms in the SND group (P < 0.001). After ablation, SNRT was 1312 ± 387 ms, with CSNRT <550 ms (392 ± 147 ms) in all patients in the NSF group. SNRT was 1492 ± 385 ms and CSNRT was 496 ± 165 ms in the SND group. CSNRT longer than 550 ms in more than 2 cycle lengths was seen in 12 patients. Ablation improved sinus node function in five patients.
In the NSF group, three patients had recurrent tachyarrhythmia at 12 months and were offered further ablation. A permanent pacemaker was implanted in one patient (1/11) with atrial flutter at half a month after operation. This patient had on going symptomatic and persistent sinus pauses on termination of tachyarrhythmia. No sinus pauses more than 2 s were observed by Holter ECG in the NSF group after successful RFCA during a 24-month follow-up period. In the SND group, permanent pacemaker implantation was performed in 8 patients (8/17) after successful ablation due to symptomatic sinus bradycardia occurring during a 2-year follow-up. A repeat ablation procedure was performed in three patients with PAF recurrence. All three patients had bradycardia without prolonged pause and permanent pacemaker implantation.
During the follow-up of 24 months, sinus rhythm was maintained in 10/11 (90.9%) NSD patients and 5/17 (29.4%) SND patients. Figure 2 illustrates the Kaplan-Meier survival curves for AF recurrence between the NSF and SND groups. A significant difference was seen in the cumulative recurrence-free rate between the two groups (P = 0.001 by log-rank test).
Predictive factors of sinus node dysfunction
The mean heart rate was observed with the maintenance of sinus rhythm after ablation during the 1 st week after ablation or at 1, 3, 6, 12, 18, and 24 months in 10 NSF group patients (10/11). Figure 3 shows the mean heart rate was significantly increased in 10 patients at the first week then 3 months after the procedure (P < 0.05), but not at 6, 12, 18, and 24 months. Multivariate analysis data suggest prolonged pauses on termination of PAF, frequency of pauses (>2.0s), and mean heart rate after ablation were independent predictive factors of SND.
discussion
Important findings
(1) progressive improvement of sinus node function was seen in some patients after elimination of PAF, suggesting that these sinus pauses may be a manifestation of tachycardia-mediated remodeling of the sinus node, and that permanent pacemaker implantation is unnecessary; (2) prolonged pauses on termination of PAF, frequency of pauses (>2.0s), and mean heart rate after ablation were independent predictive factors of SND.
In 1973, Kaplan et al. [2] defined TBS as an accepted indication for pacemaker implantation. During the past decade, catheter ablation of tachyarrhythmia has rapidly evolved. The common association between SND and atrial tachyarrhythmias has long been recognized. In 2002, Hadian et al. [10] demonstrated transient electrical remodeling of sinus node function induced by 10-15 min of rapid atrial pacing in patients without SND. In 2003, Hocini et al. [6] demonstrated in patients with documented prolonged pauses on termination of PAF, ablation to cure PAF together with the cessation of prolonged pauses resulted in no patients developing signs of SND after elimination of PAF. Their findings suggest the presence of different pathophysiologies in TBS-one related to tachyarrhythmia and the other related to intrinsic SND. As a result, one might be SND causing atrial tachyarrhythmia and the other might be atrial tachyarrhythmia itself causing SND. [11, 12] In this report, we described 28 PAF patients with prolonged pauses ranging from 3.2-12.6 s. Intracardiac electrophysiology study (EPS) was performed before RFCA procedure. Eleven patients (39.3%) were in the NSF group; 17 (60.7%) patients were in the SND group. No significant difference was found in gender, left atrial dimension, LVEF, blood pressure, and the longest pause between the two groups. Radiofrequency ablation was successful in 28 patients. CSNRT was 409 ± 152 ms in the NSF group before the ablation procedure. After ablation, CSNRT was 392 ± 147 ms in the NSF group, while CSNRT was 558 ± 178 ms before the ablation procedure in the SND group. After ablation, CSNRT was 496 ± 165 ms in the SND group. We found radiofrequency ablation may have an impact on sinus node function. Sinus node function was shown to improve following elimination of PAF in 28 patients. CSNRT longer than 550 ms in >2 cycle lengths was also noted in 8 patients after the ablation procedure. CSNRT data showed most patients in the SND group had intrinsic SND. Miyanaga, et al. found [7] that the mean heart rate did not significantly change in patients with preexisting SND after catheter-based PV isolation for PAF. Akoum et al. [13] found that in patients with AF presenting for catheter ablation, significant atrial Mean heart rate at 1 week, 1, 3, 6, 12, 18 and 24 months after radiofrequency catheter ablation in normal sinus node function group, *P < 0.05. 1 week, 1, 3 month versus before ablation fibrosis was associated with clinically significant SND. Despite improvement in the tachycardia aspect, significant SND was still present postablation. This is because structural remodeling throughout the atrium and in the sinus node region is less reversible than electrical remodeling.
Of particular interest is that EPSs in PAP patients with prolonged sinus pauses found most patients had NSF before ablation. The sinus node characteristically responds to various environmental stimuli and autonomic nervous system. Prolonged sinus occurred in paroxysmal tachyarrhythmia patients with NSF after drug administration. [14] In this article, all patients studied had prolonged sinus pauses associated with episodes of syncope or presyncope without antiarrhythmic or rate-controlling drugs. Rapid atrial rate on the sinus node automaticity has a direct inhibitory effect and leads to acute SND. [15, 16] High concentrations of adenosine (10-100 μM) can terminate tachypacing or atrial flutter/fibrillation and can produce prolonged atrial pauses. Adenosine contributes to sinus pauses through SAN exit block rather than slowed pacemaker automaticity [17] since overdrive suppression of sinus automaticity may result in long pauses and syncope when tachycardia terminates. As a result, the post-paroxysmal pause may be prolonged in the absence of SND. A correlation can be seen between the prolonged post-paroxysmal pause and the prolonged SNRTmax. However, interventions used to terminate paroxysmal atrial tachycardia may cause an increase in the concentration of liberated acetylcholine within the sinus node. As a result, the post-paroxysmal pause may be prolonged in the absence of SND. This kind of prolonged pauses phenomenon was associated with tachycardia, that paroxysmal arrhythmias caused by this "acute" or "secondary" sinus node function changes.
In our study, the mean age of the NSF group was older, the frequency of pauses was greater, the mean, minimum and maximum heart rates and CSNRT were smaller compared to the SND group. Data from a multivariate analysis suggest prolonged pauses on termination of tachyarrhythmia, frequency of pauses, and mean heart rate after ablation are independent predictors of SND. Our data also support the goals of prevention and treatment for prolonged pauses and PAF patients should be to eliminate tachyarrhythmia, and to test the sinus node function after the ablation procedure. Prolonged pauses on termination of tachyarrhythmia, frequency of pauses (>2.0 s), and mean heart rate before ablation were independent predictors of NSF. Ablation can improve the sinus node function. Some patients with intrinsic SND may require pacing even after the PAF has been eliminated.
Study limitations
Our study has several limitations. First, it was retrospective and involved a small number of patients who had prolonged pauses with tachyarrhythmia. Second, because our study excluded antiarrhythmic users, and many patients fail recorded ECG data on termination of the arrhythmia, the actual rate of patients who had prolonged pauses only on termination of tachyarrhythmia may be significantly higher than we reported.
conclusions
The main findings of this study are as follows: (1) catheter ablation of AF is effective in treating paroxysmal AF-related TBS; (2) in some patients, there is progressive improvement of sinus node function after elimination of AF, suggesting that sinus pauses may be a manifestation of tachycardia-mediated remodeling of the sinus node, and that permanent pacemaker implantation is not necessary; (3) among the extrinsic and intrinsic causes of SND, intrinsic causes are seldom reversible while some causes of extrinsic SND may be reversible; and (4) prolonged pauses on termination of PAF, frequency of pauses (>2.0 s), and mean heart rate after ablation were independent predictive factors of SND.
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